SCHEMBL26016793

SCHEMBL26016793

C=CC(=O)N1CCN(c2nc(OC)nc3c2CCCN(c2cccc4cccc(C)c24)CC3)C[C@@H]1CC#N

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.70
▸ SOS1 Q07889 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21786275 0.98 KRAS (0.69) KRASSOS1
SCHEMBL26019261 0.87 KRAS (0.66) KRASSOS1
SCHEMBL23074830 0.87 KRAS (0.92) KRASSOS1
SCHEMBL23074885 0.87 KRAS (0.92) KRASSOS1
SCHEMBL23074835 0.87 KRAS (0.92) KRASSOS1
SCHEMBL23282263 0.85 KRAS (0.81) KRAS
SCHEMBL23282275 0.85 KRAS (0.81) KRAS
SCHEMBL19637319 0.85 KRAS (0.69) KRAS
SCHEMBL28793543 0.84 KRAS (0.79) KRAS
SCHEMBL23074934 0.84 KRAS (0.62) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3844151-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-08-23 — — EP disclosed
Send feedback